Advertisement

Bleeding and Coagulopathy

  • Janice P. Dutcher

Abstract

Anemia is not an uncommon finding in patients with malignancy, and the etiology is often multifactorial. In patients with hematologic malignancies, anemia is usually due to the lack of production of red blood cells, rather than blood loss, but it may be due to both. In patients with solid tumors, the anemia is usually that of chronic disease, a state of impaired iron utilization and therefore decreased blood production.1–3

Keywords

Human Leukocyte Antigen Acute Leukemia Disseminate Intravascular Coagulation Disseminate Intravascular Coagulation Platelet Transfusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bentley DP: Anemia and chronic disease. Clin Haematol 11: 465–477, 1982.PubMedGoogle Scholar
  2. 2.
    Cartwright GE: The anemia of chronic disorders. Semin Hematol 3: 351–374, 1966.PubMedGoogle Scholar
  3. 3.
    Cartwright GE, Lee GR: Annotation: The anemia of chronic disorders. Br J Haematol 21: 147–152, 1971.PubMedCrossRefGoogle Scholar
  4. 4.
    Dutcher JP, Schiffer CA, Aisner J, et al: Incidence of thrombocytopenia and bleeding among patients with solid tumors. Cancer 53: 557–562, 1984.PubMedCrossRefGoogle Scholar
  5. 5.
    Roy AJ, Jafe N, Djerassi I: Prophylactic platelet transfusions in children with acute leukemia: A dose-response study. Transfusion 13: 283–290, 1973.PubMedCrossRefGoogle Scholar
  6. 6.
    Schiffer CA, Aisner J: Platelet and granulocyte transfusion therapy for patients with cancer, Petz LD, Swisher SN (eds): Clinical Practice of Blood Transfusion. New York, Churchill Livingstone, 1981, pp 551–572.Google Scholar
  7. 7.
    Schiffer CA, Aisner J, Daly PA: Platelet transfusion for thrombocytopenic cancer patients, Klastersky J, Staquet MJ (eds): Medical Complications in Cancer Patients. New York, Raven Press, 1981, pp 37–49.Google Scholar
  8. 8.
    Dutcher JP, Schiffer CA, Aisner J, et al: Alloimmunization following platelet transfusion: The absence of a dose-response relationship. Blood 57: 395–398, 1981.PubMedGoogle Scholar
  9. 9.
    Halohan TV, Terasaki PH, Deisseroth AB: Suppression of transfusion-related alloimmunization in intensively treated cancer patients. Blood 58: 122–128, 1981.Google Scholar
  10. 10.
    Hogge DE, Dutcher JP, Aisner J, Schiffer CA: Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol 14: 363–369, 1983.PubMedCrossRefGoogle Scholar
  11. 11.
    Daly PA, Schiffer CA, Aisner J, Wiernik PH: Platelet transfusion therapy: One hour post-transfusion increments are valuable in predicting the need for HLA-matched preparations. J Am Med Assoc 243: 435–438, 1980.CrossRefGoogle Scholar
  12. 12.
    Schiffer CA, Aisner J, Wiernik PH: Frozen autologous platelet transfusion for patients with leukemia. N Engl J Med 299: 7–12, 1978.PubMedCrossRefGoogle Scholar
  13. 13.
    Sack GM, Levin J, Bell WR: Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic and therapeutic features. Medicine (Baltimore) 56: 1–37, 1977.Google Scholar
  14. 14.
    Rickles FR, Edwards RL: Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 62: 14–31, 1983.PubMedGoogle Scholar
  15. 15.
    Brain MC, Azzopardi JG, Baker LRI: Microangiopathic haemolytic anemia in mucin-forming adenocarcinoma. Br J Haematol 18: 183–193, 1970.PubMedCrossRefGoogle Scholar
  16. 16.
    Shafer AI: The hypercoagulable states. Ann Intern Med 102: 814–828, 1985.CrossRefGoogle Scholar
  17. 17.
    Gore JM, Applebaum JS, Greene HL, Dixter L, Dalen JE: Occult cancer in patients with acute pulmonary embolism. Ann Intern Med 96: 556–560, 1982.PubMedCrossRefGoogle Scholar
  18. 18.
    Daly PA, Schiffer CA, Wiernik PH: Acute progranulocytic leukemia—Clinical management of 15 patients. Am J Hematol 8: 347–359, 1980.PubMedCrossRefGoogle Scholar
  19. 19.
    Gralnick HK, Bagley J, Abrel E: Heparin treatment for the hemorrhagic diathesis of acute progranulocytic leukemia. Am J Med 52: 167–174, 1971.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Janice P. Dutcher

There are no affiliations available

Personalised recommendations